Journal of International Oncology ›› 2022, Vol. 49 ›› Issue (2): 65-72.doi: 10.3760/cma.j.cn371439-20210831-00010
-
Received:2021-08-31Revised:2021-11-20Online:2022-02-08Published:2022-03-11
Cite this article
share this article
"
| 发病部位 | Ⅰ区 | Ⅱ区 | Ⅲ区 | Ⅳ区 | Ⅴ区 |
|---|---|---|---|---|---|
| 扁桃体 | 9 | 88 | 23 | 9 | 10 |
| 舌根 | 6 | 76 | 24 | 9 | 7 |
| 舌侧缘 | 5 | 38 | 19 | 19 | 5 |
| 舌腹 | 19 | 38 | 19 | 19 | 5 |
| 颊黏膜 | 62 | 31 | 8 | 0 | 0 |
| 上牙龈 | 14 | 57 | 14 | 14 | 0 |
| 下牙龈 | 46 | 38 | 15 | 0 | 0 |
| 磨牙后三角 | 19 | 71 | 5 | 5 | 0 |
| 口底 | 46 | 29 | 14 | 11 | 0 |
| 口咽 | 3 | 67 | 14 | 10 | 5 |
| 下咽 | 10 | 78 | 75 | 47 | 11 |
| 喉 | 8 | 68 | 70 | 35 | 5 |
| [1] |
Marur S, Forastiere AA. Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment[J]. Mayo Clin Proc, 2016, 91(3): 386-396. DOI: 10.1016/j.mayocp.2015.12.017.
doi: 10.1016/j.mayocp.2015.12.017 |
| [2] |
Amsbaugh MJ, Yusuf M, Cash E, et al. Distribution of cervical lymph node metastases from squamous cell carcinoma of the oropha-rynx in the era of risk stratification using human papillomavirus and smoking status[J]. Int J Radiat Oncol Biol Phys, 2016, 96(2): 349-353. DOI: 10.1016/j.ijrobp.2016.06.2450.
doi: 10.1016/j.ijrobp.2016.06.2450 |
| [3] |
Chung EJ, Lee SH, Baek SH, et al. Pattern of cervical lymph node metastasis in medial wall pyriform sinus carcinoma[J]. Laryngoscope, 2014, 124(4): 882-887. DOI: 10.1002/lary.24299.
doi: 10.1002/lary.24299 |
| [4] |
Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract[J]. Am J Surg, 1990, 160(4): 405-409. DOI: 10.1016/s0002-9610(05)80554-9.
doi: 10.1016/s0002-9610(05)80554-9 pmid: 2221244 |
| [5] |
Wacławek M, Miłoński J, Olszewski J. Comparative evaluation of the diagnostic value of biopsy and NBI endoscopy in patients with cancer of the hypopharynx and larynx[J]. Otolaryngol Pol, 2019, 73(5): 12-17. DOI: 10.5604/01.3001.0013.2309.
doi: 10.5604/01.3001.0013.2309 |
| [6] |
Tanaka S, Morita Y, Fujita T, et al. Clinicopathological characteristics of abnormal micro-lesions at the oro-hypopharynx detected by a magnifying narrow band imaging system[J]. Dig Endosc, 2012, 24(2): 100-109. DOI: 10.1111/j.1443-1661.2011.01177.x.
doi: 10.1111/j.1443-1661.2011.01177.x |
| [7] |
Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas[J]. J Nucl Med, 1995, 36(10): 1747-1757.
pmid: 7562038 |
| [8] |
Yao M, Smith RB, Hoffman HT, et al. Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer—a long-term outcome report[J]. Int J Radiat Oncol Biol Phys, 2009, 74(1): 9-14. DOI: 10.1016/j.ijrobp.2008.07.019.
doi: 10.1016/j.ijrobp.2008.07.019 |
| [9] |
Porceddu SV, Jarmolowski E, Hicks RJ, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer[J]. Head Neck, 2005, 27(3): 175-181. DOI: 10.1002/hed.20130.
doi: 10.1002/hed.20130 |
| [10] |
田家军, 徐伟, 吕正华, 等. 电子胃镜在下咽鳞状细胞癌术前检查中的应用[J]. 中华耳鼻咽喉头颈外科杂志, 2018, 53(4): 292-295. DOI: 10.3760/cma.j.issn.1673-0860.2018.04.010.
doi: 10.3760/cma.j.issn.1673-0860.2018.04.010 |
| [11] |
Huang YC, Lee YC, Tseng PH, et al. Regular screening of esophageal cancer for 248 newly diagnosed hypopharyngeal squamous cell carcinoma by unsedated transnasal esophagogastroduodenoscopy[J]. Oral Oncol, 2016, 55:55-60. DOI: 10.1016/j.oraloncology.2016.01.008.
doi: 10.1016/j.oraloncology.2016.01.008 |
| [12] |
Boute P, Page C, Biet A, et al. Epidemiology, prognosis and treatment of simultaneous squamous cell carcinomas of the oral cavity and hypopharynx[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2014, 131(5): 283-287. DOI: 10.1016/j.anorl.2013.10.003.
doi: 10.1016/j.anorl.2013.10.003 pmid: 25288121 |
| [13] |
Wycliffe ND, Grover RS, Kim PD, et al. Hypopharyngeal cancer[J]. Top Magn Reson Imaging, 2007, 18(4): 243-258. DOI: 10.1097/RMR.0b013e3181570c3f.
doi: 10.1097/RMR.0b013e3181570c3f |
| [14] |
Tandon S, Shahab R, Benton JI, et al. Fine-needle aspiration cyto-logy in a regional head and neck cancer center: comparison with a systematic review and meta-analysis[J]. Head Neck, 2008, 30(9): 1246-1252. DOI: 10.1002/hed.20849.
doi: 10.1002/hed.20849 |
| [15] |
Adoga AA, Silas OA, Nimkur TL. Open cervical lymph node biopsy for head and neck cancers: any benefit?[J]. Head Neck Oncol, 2009, 1:9. DOI: 10.1186/1758-3284-1-9.
doi: 10.1186/1758-3284-1-9 |
| [16] |
Chow LQM. Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. DOI: 10.1056/NEJMra1715715.
doi: 10.1056/NEJMra1715715 |
| [17] |
Braakhuis BJ, Brakenhoff RH, Leemans CR. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors[J]. Ann Oncol, 2012, 23(Suppl 10): x173-x177. DOI: 10.1093/annonc/mds299.
doi: 10.1093/annonc/mds299 |
| [18] |
Eskander A, Irish J, Groome PA, et al. Volume-outcome relationships for head and neck cancer surgery in a universal health care system[J]. Laryngoscope, 2014, 124(9): 2081-2088. DOI: 10.1002/lary.24704.
doi: 10.1002/lary.24704 |
| [19] | National Comprehensive Cancer Network. NCCN Guidelines Version 2.2021 Head and Neck Cancers[S]. Pennsylvania: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), 2021. |
| [20] |
Howard J, Dwivedi RC, Masterson L, et al. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma[J]. Cochrane Database Syst Rev, 2018, 12(12): CD012939. DOI: 10.1002/14651858.CD012939.pub2.
doi: 10.1002/14651858.CD012939.pub2 |
| [21] |
Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetu-ximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial[J]. Lancet, 2019, 393(10166): 40-50. DOI: 10.1016/S0140-6736(18)32779-X.
doi: S0140-6736(18)32779-X pmid: 30449625 |
| [22] |
Patel SH, Wang Z, Wong WW, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis[J]. Lancet Oncol, 2014, 15(9): 1027-1038. DOI: 10.1016/S1470-2045(14)70268-2.
doi: 10.1016/S1470-2045(14)70268-2 |
| [23] |
Akbaba S, Ahmed D, Lang K, et al. Results of a combination treatment with intensity modulated radiotherapy and active raster-scanning carbon ion boost for adenoid cystic carcinoma of the minor salivary glands of the nasopharynx[J]. Oral Oncol, 2019, 91:39-46. DOI: 10.1016/j.oraloncology.2019.02.019.
doi: S1368-8375(19)30064-8 pmid: 30926061 |
| [24] |
Ikawa H, Koto M, Hayashi K, et al. Feasibility of carbon-ion radiotherapy for oral non-squamous cell carcinomas[J]. Head Neck, 2019, 41(6): 1795-1803. DOI: 10.1002/hed.25618.
doi: 10.1002/hed.25618 |
| [25] |
Blanchard P, Gunn GB, Lin A, et al. Proton therapy for head and neck cancers[J]. Semin Radiat Oncol, 2018, 28(1): 53-63. DOI: 10.1016/j.semradonc.2017.08.004.
doi: S1053-4296(17)30085-1 pmid: 29173756 |
| [26] |
Lv X, Cao X, Xia WX, et al. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage Ⅲ-ⅣB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial[J]. Lancet Oncol, 2021, 22(5): 716-726. DOI: 10.1016/S1470-2045(21)00075-9.
doi: 10.1016/S1470-2045(21)00075-9 |
| [27] |
陈宇, 吴伟莉, 金风, 等. 时间调节诱导化疗序贯洛铂同期放化疗治疗局部晚期头颈部鳞癌临床分析[J]. 肿瘤防治研究, 2017, 44(10): 689-693. DOI: 10.3971/j.issn.1000-8578.2017.17.0031.
doi: 10.3971/j.issn.1000-8578.2017.17.0031 |
| [28] |
Zeng YC, Wu R, Xu ZG, et al. Safety and radiation-enhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinum-containing chemotherapy regimens: a preliminary report[J]. Cancer Radiother, 2010, 14(1): 59-64. DOI: 10.1016/j.canrad.2009.06.022.
doi: 10.1016/j.canrad.2009.06.022 pmid: 19695922 |
| [29] |
Patil VM, Noronha V, Joshi A, et al. A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer[J]. Cancer, 2019, 125(18): 3184-3197. DOI: 10.1002/cncr.32179.
doi: 10.1002/cncr.32179 |
| [30] |
王健仰, 黄晓东, 王凯, 等. 甘氨双唑钠降低头颈部鳞癌患者严重放射性黏膜炎的Ⅱ期随机临床研究[J]. 中华放射肿瘤学杂志, 2016, 25(7): 671-675. DOI: 10.3760/cma.j.issn.1004-4221.2016.07.002.
doi: 10.3760/cma.j.issn.1004-4221.2016.07.002 |
| [31] | Wen Q, Ma QJ, Bai L, et al. Glycididazole sodium combined with radioiodine therapy for patients with differentiated thyroid carcinoma (DTC)[J]. Int J Clin Exp Med, 2015, 8(8): 14095-14099. |
| [32] |
Lin HW, Bhattacharyya N. Contemporary assessment of medical morbidity and mortality in head and neck surgery[J]. Otolaryngol Head Neck Surg, 2012, 146(3): 385-389. DOI: 10.1177/0194599811428557.
doi: 10.1177/0194599811428557 |
| [33] |
Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review[J]. Radiother Oncol, 2003, 66(3): 253-262. DOI: 10.1016/s0167-8140(02)00404-8.
doi: 10.1016/s0167-8140(02)00404-8 pmid: 12742264 |
| [34] |
Vissink A, Mitchell JB, Baum BJ, et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers[J]. Int J Radiat Oncol Biol Phys, 2010, 78(4): 983-991. DOI: 10.1016/j.ijrobp.2010.06.052.
doi: 10.1016/j.ijrobp.2010.06.052 |
| [35] |
Sapir E, Tao Y, Feng F, et al. Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2016, 96(2): 354-361. DOI: 10.1016/j.ijrobp.2016.05.011.
doi: 10.1016/j.ijrobp.2016.05.011 |
| [36] |
Siddiqui F, Movsas B. Management of radiation toxicity in head and neck cancers[J]. Semin Radiat Oncol, 2017, 27(4): 340-349. DOI: 10.1016/j.semradonc.2017.04.008.
doi: S1053-4296(17)30039-5 pmid: 28865517 |
| [37] |
De Felice F, Musio D, Tombolini V. Osteoradionecrosis and intensity modulated radiation therapy: an overview[J]. Crit Rev Oncol Hematol, 2016, 107:39-43. DOI: 10.1016/j.critrevonc.2016.08.017.
doi: 10.1016/j.critrevonc.2016.08.017 |
| [38] |
Hermans R, Fossion E, Ioannides C, et al. CT findings in osteoradionecrosis of the mandible[J]. Skeletal Radiol, 1996, 25(1): 31-36. DOI: 10.1007/s002560050028.
doi: 10.1007/s002560050028 pmid: 8717116 |
| [39] |
Chen AM, Hall WH, Li BQ, et al. Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer[J]. Br J Radiol, 2011, 84(997): 58-63. DOI: 10.1259/bjr/62332495.
doi: 10.1259/bjr/62332495 pmid: 20858665 |
| [40] |
Chen AM, Hall WH, Li J, et al. Brachial plexus-associated neuro-pathy after high-dose radiation therapy for head-and-neck cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 84(1): 165-169. DOI: 10.1016/j.ijrobp.2011.11.019.
doi: 10.1016/j.ijrobp.2011.11.019 |
| [41] |
Chen J, Dassarath M, Yin Z, et al. Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management[J]. Radiat Oncol, 2011, 6:128. DOI: 10.1186/1748-717X-6-128.
doi: 10.1186/1748-717X-6-128 |
| No related articles found! |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||